| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/01/2009 | CA2432428C Quinazoline derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 09/01/2009 | CA2431206C Combination drugs containing anti-sepsis cycloalkene compound |
| 09/01/2009 | CA2417727C Fentanyl composition for nasal administration |
| 09/01/2009 | CA2400804C Stable emulsion compositions of cycloalkene derivatives |
| 09/01/2009 | CA2385867C Sustained release form comprising alpha-lipoic acid or derivatives thereof |
| 09/01/2009 | CA2379147C Percutaneously absorbable preparations |
| 09/01/2009 | CA2210812C T-cell affecting peptides |
| 08/27/2009 | WO2009105712A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 08/27/2009 | WO2009105629A2 Methods for the treatment and prevention of necrotizing enterocolitis |
| 08/27/2009 | WO2009105509A1 Amine and ether compounds which modulate the cb2 receptor |
| 08/27/2009 | WO2009105435A1 Inhibitors of the chemokine receptor cxcr3 |
| 08/27/2009 | WO2009104388A1 Prophylactic/therapeutic agent for collagenosis |
| 08/27/2009 | WO2009103932A1 Use of a cardiac glycoside and/or a diuretic for the treatment of neuropathic pain |
| 08/27/2009 | WO2009103487A1 Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| 08/27/2009 | WO2009103176A1 Nitrogen-containing bycyclic compounds active on chronic pain conditions |
| 08/27/2009 | WO2009082526A3 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
| 08/27/2009 | WO2009065395A3 Novel use of omega-3-fatty acid(s) |
| 08/27/2009 | WO2008116145A3 Soluble epoxide hydrolase inhibitors |
| 08/27/2009 | US20090217392 Anti- integrin antibodies, compositions, methods and uses |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215904 Colchicine compositions and methods |
| 08/27/2009 | US20090215903 Injectable Liquid Paracetamol Formulation |
| 08/27/2009 | US20090215895 Therapeutic and carrier molecules |
| 08/27/2009 | US20090215891 S-[2-[(1-lminoethy)Amino]Ethyl]-2-Methyl-L-Cysteine Maleate Hydrochloride Crystalline Salt |
| 08/27/2009 | US20090215890 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 08/27/2009 | US20090215886 Anti-Inflammatory Formulation |
| 08/27/2009 | US20090215861 Antisense oligonucleotides for treating allergy and neoplastic cell proliferation |
| 08/27/2009 | US20090215834 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/27/2009 | US20090215829 Thiophene carboxamides as inhibitors of the enzyme ikk-2 |
| 08/27/2009 | US20090215827 Inhibitors of cxcr2 |
| 08/27/2009 | US20090215817 Novel Triazolopyridine Compounds for the Treatment of Inflammation |
| 08/27/2009 | US20090215809 crystalline calcium (3S)-{[(1R)-isobutanoyloxyethoxy]carbonylaminomethyl}-5-methyl-hexanoate hydrate; sustained release oral dosage formualtion with opioid agonist, selective serotonin re-uptake inhibitor and noradrenaline re-uptake inhibitor; an inflammatory disease, neuropathic pain, anxiety, psychosis |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215750 Pyrrolopyrazine kinase inhibitors |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215727 Inhibition of atp-mediated, p2x7 dependent pathways by pyridoxal-5-phosphate and vitamin b6 related compounds |
| 08/27/2009 | US20090215724 Pyrrolopyrazine kinase inhibitors |
| 08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
| 08/27/2009 | US20090215076 Methods and substances for the diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 08/27/2009 | US20090214630 Compositions and Methods for the Treatment of Inflammatory Bowel Disease Utilizing NF-KappaB Decoy Polynucleotides |
| 08/27/2009 | US20090214572 Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders |
| 08/27/2009 | US20090214557 Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (i) interferon producing cells |
| 08/27/2009 | US20090214549 Antigenic Epitopes Of Inteleukin-21, Related Antibodies And Their Use In Medical Field |
| 08/27/2009 | US20090214519 Compositions and Methods for Treating Inflammation |
| 08/27/2009 | CA2716515A1 Amine and ether compounds which modulate the cb2 receptor |
| 08/27/2009 | CA2716230A1 Nitrogen-containing bycyclic compounds active on chronic pain conditions |
| 08/27/2009 | CA2715557A1 Inhibitors of the chemokine receptor cxcr3 |
| 08/27/2009 | CA2714700A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 08/27/2009 | CA2712640A1 Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093214A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 08/26/2009 | EP2092935A1 Pharmaceutical compositions for the treatment of asthma |
| 08/26/2009 | EP2091544A2 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 08/26/2009 | EP2091540A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain. |
| 08/26/2009 | EP1603899B1 Heterocyclic urea derivatives for the treatment of pain |
| 08/26/2009 | EP1536840B1 Formulation for inwardly transferring nucleic acids into eucaryotic cells |
| 08/26/2009 | EP1485087B1 (+)-2- [1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione for use in treating psoriasis by oral administration |
| 08/26/2009 | EP1389096B9 Delivery of opioids through an inhalation route |
| 08/26/2009 | EP1218375B1 Pharmaceutically active sulfonyl amino acid derivatives |
| 08/26/2009 | EP1061812B1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 08/26/2009 | CN101516887A Thiazole pyrazolopyrimidines as CRF1 receptor antagonists |
| 08/26/2009 | CN101516869A Heterocyclic substituted piperazine compounds with CXCR3 antagonist activity |
| 08/26/2009 | CN101516839A Compounds which modulate the cb2 receptor |
| 08/26/2009 | CN101516386A Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders |
| 08/26/2009 | CN101516329A Cell activator, collagen production promoter, collagenase activity inhibitor, melanin formation inhibitor, antioxidant agent, antiinflammatory agent, fat accumilation inhibitor, external preparation f |
| 08/26/2009 | CN101514333A Immunologic tolerance dendritic cell, preparation method thereof and special culture medium |
| 08/26/2009 | CN101513533A Method for building models of various diseases in one rat body and application thereof |
| 08/26/2009 | CN101513522A Chinese medical herbs aerosols for treating anchylosis, painful swelling and preparation method thereof |
| 08/26/2009 | CN101513477A Analgesic medicine for external application and method for preparing same |
| 08/26/2009 | CN101513469A Chinese medicinal composition for resisting rheumatoid arthritis, and preparation method thereof |
| 08/26/2009 | CN101513466A Method for preparing quinoline alkaloid from zanthoxylum dissitum Hemsl |
| 08/26/2009 | CN101513457A Cold rheumatism formula |
| 08/26/2009 | CN101513452A Decumbent corydalis tuber cataplasm and preparation method thereof |
| 08/26/2009 | CN101513436A Szechuan lovage rhizome-angelica total extract, preparation and application |
| 08/26/2009 | CN101513424A An injection for treating unknown high fever of pig |
| 08/26/2009 | CN101513423A Application of oleanane-28-acid-2,9(11),12-triene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513422A Application of oleanane-28-carboxylic methyl ether-2,11,13(18)-triene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513421A Application of 28-hydroxy-oleanane-2,11,13(18)-triene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513420A Application of 28-hydroxy-oleanane-2,9(11),12-triene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513419A Application of 11-hydroxy-oleanane-28-acid-2,12-diene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513418A Application of 1,11-dyhydroxy-oleanane-28-acid-2,12-diene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513417A Application of 1-hydroxy-oleanane-28-acid-2,12-diene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513416A Application of 1-acetoxyl group-oleanane-28-acid-2,12-diene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513415A Application of 1-hydroxy-oleanane-28-carboxylic methyl ether-2,12-diene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513414A Application of 1-acetoxyl group-oleanane-28-carboxylic methyl ether-2,12-diene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513413A Application of 1,11,28-trihydroxy-oleanane-2,12-diene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513412A Application of 1,28-dyhydroxy-oleanane-2,12-diene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513411A Application of oleanane-28-acid-2,11,13(18)-triene in preparing medicament for treating skin diseases |
| 08/26/2009 | CN101513396A Method for preparing ciprofloxacin hydrochloride time-release capsule |
| 08/26/2009 | CN101513391A Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 08/26/2009 | CN101513386A Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 08/26/2009 | CN100533141C Detection method for trauma treating Diedahongyao preparation |
| 08/26/2009 | CN100531795C Omega-conotoxin M VII A mutant and its preparation and uses |
| 08/26/2009 | CN100531789C Chinese medicine for treating injury |
| 08/26/2009 | CN100531763C Damp-repellent pain-relieving medicinal liquor of Herba Underniae Antipodae |
| 08/26/2009 | CN100531760C Chinese medicinal preparation for eliminating inflammation and relieving pain and use thereof |
| 08/26/2009 | CN100531756C Externally used Chinese traditional medicine for treating osteopathy |
| 08/26/2009 | CN100531755C Preparation process of superfine Chinese medicine powder preparation for treating rheumatic disease |
| 08/25/2009 | US7579494 Prevention of neutrophil recruitment |
| 08/25/2009 | US7579455 Antisense agents against genes coding for phosphodiesterase; for treatment of asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, bronchitis, chronic bronchitis, silicosis, pulmonary fibrosis, lung allograft rejection, allergic rhinitis and chronic sinusitis |